Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
about
Madurella mycetomatis is highly susceptible to ravuconazoleManagement of histoplasmosis.New and emerging antifungal agents: impact on respiratory infections.Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Synthesis, Biological Evaluation and Molecular Docking of Certain Sulfones as Potential Nonazole Antifungal Agents.Newer antifungal agents.Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.
P2860
Q28539848-9715FD1C-F80E-47B7-9516-F86964C4EF6FQ34768480-7D8DB628-1785-44C9-82E4-8477D0208BDFQ35627629-0375CFD0-97C1-4F4E-A1EF-6A352E786534Q36491819-21D6E9FC-0AF0-493D-B372-A099C46969F5Q36669593-0D74C7CC-8660-4A1A-924F-0B8D3ABF3812Q37119029-271BF67A-4BB3-4EB5-9504-985BC4BB6D4CQ37918556-3FF48E5C-D751-40C8-8770-9D35C2F4245EQ38799849-9B16F9E8-E776-4C0C-B649-089EB3F6F1D1Q44855715-CC718057-443A-4E59-B2AF-C3B37FD5D98FQ46711208-B4328D77-C103-4CD5-9844-AE5E2A0260B8
P2860
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@ast
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@en
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@nl
type
label
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@ast
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@en
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@nl
prefLabel
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@ast
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@en
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@nl
P2093
P2860
P1476
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
@en
P2093
Calderon L
Clemons KV
Martinez M
Stevens DA
P2860
P304
P356
10.1128/AAC.46.3.922-924.2002
P407
P577
2002-03-01T00:00:00Z